
@article{kuger_novel_2014,
	title = {Novel {PI3K} and {mTOR} {Inhibitor} {NVP}-{BEZ235} {Radiosensitizes} {Breast} {Cancer} {Cell} {Lines} under {Normoxic} and {Hypoxic} {Conditions}:},
	shorttitle = {Novel {PI3K} and {mTOR} {Inhibitor} {NVP}-{BEZ235} {Radiosensitizes} {Breast} {Cancer} {Cell} {Lines} under {Normoxic} and {Hypoxic} {Conditions}},
	url = {https://journals.sagepub.com/doi/10.4137/BCBCR.S13693?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0www.ncbi.nlm.nih.gov},
	doi = {10.4137/BCBCR.S13693},
	abstract = {In the present study, we assessed, if the novel dual phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitor NVP-BEZ235 radiosensiti...},
	language = {en},
	urldate = {2020-06-23},
	journal = {Breast Cancer: Basic and Clinical Research},
	author = {Kuger, Sebastian and Cörek, Emre and Polat, Bülent and Kämmerer, Ulrike and Flentje, Michael and Djuzenova, Cholpon S.},
	month = mar,
	year = {2014},
	note = {Publisher: SAGE PublicationsSage UK: London, England},
	file = {Snapshot:C\:\\Users\\EmreC\\Zotero\\storage\\KZDMETXB\\BCBCR.html:text/html;Volltext:C\:\\Users\\EmreC\\Zotero\\storage\\7UZTHNKL\\Kuger et al. - 2014 - Novel PI3K and mTOR Inhibitor NVP-BEZ235 Radiosens.pdf:application/pdf}
}
